Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance

被引:28
|
作者
Wekerle, T
Nikolic, B
Pearson, DA
Swenson, KG
Sykes, M
机构
[1] Vienna Gen Hosp, Div Transplantat, Dept Surg, A-1090 Vienna, Austria
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, BMT Sect,Transplantat Biol Res Ctr, Boston, MA 02129 USA
关键词
tolerance; mixed chimerism; bone marrow transplantation; T cell depletion;
D O I
10.1007/s00147-002-0411-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
In a recently developed murine model for the induction of mixed chimerism and tolerance, hosts are treated with T cell depleting monoclonal antibodies (TCD mAbs; days -5, -1 and +7), thymic irradiation (TI) (7 Gy), and a high dose of fully allogeneic bone marrow cells (BMC, 200x10(6)). To find the minimum amount of each treatment required for success with this approach, we treated groups with (1) a lower dose of TI (3.5 Gy), (2) fewer BMC (100x10(6)), (3) no TI, (4) no TI plus additional TCD mAbs on day + 14, or (5) fewer injections of TCD mAbs (day -5 only). Chimerism was followed by flow cytometry (FCM), and tolerance was assessed by skin grafting. Without TI, no long-term chimerism or tolerance could be induced, even when an additional dose of TCD mAbs was administered on day +14. A reduction in the dose of either BMC or TI led to substantially reduced effectiveness, as demonstrated by lower levels of chimerism and poorer donor skin graft survival. However, the dose of TCD mAbs and hence the duration of recipient T cell depletion could be safely reduced and thus the potential toxicity of the conditioning regimen lowered.
引用
收藏
页码:248 / 253
页数:6
相关论文
共 50 条
  • [31] Commentary on "Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning"
    Tsoulfas, Georgios
    JOURNAL OF SURGICAL RESEARCH, 2013, 185 (01) : E37 - E38
  • [32] MINIMAL RESIDUAL DISEASE IS MORE COMMON IN PATIENTS WHO HAVE MIXED T-CELL CHIMERISM AFTER BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    MACKINNON, S
    BARNETT, L
    HELLER, G
    OREILLY, RJ
    BLOOD, 1994, 83 (11) : 3409 - 3416
  • [33] MINIMAL RESIDUAL DISEASE IS MORE COMMON IN PATIENTS WHO HAVE MIXED T-CELL CHIMERISM FOLLOWING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    MACKINNON, S
    BARNETT, L
    HELLER, G
    OREILLY, RJ
    BLOOD, 1993, 82 (10) : A169 - A169
  • [34] An irradiation-free nonmyeloablative bone marrow transplantation model: Importance of the balance between donor T-cell number and the intensity of conditioning
    Kuwatani, M
    Ikarashi, Y
    Mineishi, S
    Asaka, M
    Wakasugi, H
    TRANSPLANTATION, 2005, 80 (09) : 1145 - 1152
  • [35] T Regulatory Cell-Associated Tolerance Induction by High-Dose Immunoglobulins in an HLA-Transgenic Mouse Model of Pemphigus
    Hudemann, Christoph
    Hoffmann, Jochen
    Schmidt, Enno
    Hertl, Michael
    Eming, Ruediger
    CELLS, 2023, 12 (09)
  • [36] Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow
    Anam, K
    Akpinar, E
    Craighead, N
    Black, AT
    Hale, DA
    TRANSPLANTATION, 2004, 78 (09) : 1290 - 1298
  • [37] COMPARISON OF HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR T-CELL AND B-CELL NON-HODGKINS-LYMPHOMAS
    VOSE, JM
    PETERSON, C
    BIERMAN, PJ
    WEISENBURGER, DD
    LINDER, J
    HARRINGTON, D
    VAUGHAN, WP
    KESSINGER, A
    ARMITAGE, JO
    BLOOD, 1990, 76 (02) : 424 - 431
  • [38] ENGRAFTMENT FOLLOWING T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION .2. STABILITY OF MIXED CHIMERISM IN SEMIALLOGENEIC RECIPIENTS AFTER TOTAL-BODY IRRADIATION
    FERRARA, JLM
    MAUCH, P
    MCINTYRE, J
    MICHAELSON, J
    BURAKOFF, SJ
    TRANSPLANTATION, 1987, 44 (04) : 495 - 499
  • [39] Irradiation and T Cell Depletion Augment Bone Marrow-Derived Chimerism at the Cost of Morbidity and Mortality in a Non-Human Primate Model of Vascularized Composite Allotransplantation.
    Brazio, P.
    Ha, J.
    Munivenkatappa, R.
    Mohan, R.
    Rodriguez, E.
    Bartlett, S.
    Barth, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 476 - 476
  • [40] FAILURE OF HIGH-DOSE RADIOTHERAPY TO ABROGATE GRAFT-REJECTION FOLLOWING T-CELL DEPLETED BONE-MARROW TRANSPLANTATION (BMT)
    CHAMPLIN, R
    HO, W
    GALE, RP
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 536 - 536